RNA splicing manipulation: strategies to modify gene expression for a variety of therapeutic outcomes.
about
Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotidesAntisense oligonucleotide induced exon skipping and the dystrophin gene transcript: cocktails and chemistriesEnhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exon.Dynamics of co-transcriptional pre-mRNA folding influences the induction of dystrophin exon skipping by antisense oligonucleotides.A small molecule that targets r(CGG)(exp) and improves defects in fragile X-associated tremor ataxia syndrome.Human Splicing Finder: an online bioinformatics tool to predict splicing signals.Antisense oligonucleotide induction of progerin in human myogenic cellsIncrease of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells.mRNA transcript diversity creates new opportunities for pharmacological intervention.Defective splicing, disease and therapy: searching for master checkpoints in exon definition.Potential therapeutic applications of antisense morpholino oligonucleotides in modulation of splicing in primary immunodeficiency diseasesRNA-based therapeutic approaches for coagulation factor deficiencies.A generalizable pre-clinical research approach for orphan disease therapySR protein-mediated inhibition of CFTR exon 9 inclusion: molecular characterization of the intronic splicing silencer.Tetracycline aptamer-controlled regulation of pre-mRNA splicing in yeast.The biomarker and therapeutic potential of miRNA in Alzheimer's disease.Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes.An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements.Noncoding RNAs and Duchenne muscular dystrophy.
P2860
Q24645148-424668A6-8E45-4312-A05D-A2DEFAB7C88EQ27480935-D0A1BE25-E6C3-403C-876C-00BB30805140Q33278100-8FB9E60E-4406-4D43-9447-2C50B49E05F8Q33325470-47C6CAD5-5EB0-44DD-A3D3-33A7A707CF3AQ34403150-8970CB01-AC32-4EE1-8946-2A6A4CEC6557Q34973311-FEF0371A-A345-4E6E-9D57-D56BDC69CC2AQ35180565-DC1FA5AC-6057-4EA7-B9F9-7949E5849A37Q35301892-D9F8AA94-564B-4B88-ADC1-1829AC923183Q35913120-988E19C0-F1ED-406E-8967-B2CEA6D4298EQ36541361-FA5B1351-C248-4BA3-B41E-A789A45302E0Q37819299-DCA6A2DE-2B41-4A3E-AFDB-39A90131FCAEQ37919973-6C6D49F1-72AC-46BD-9796-DC527B3F7FD0Q38019219-0B784DE9-7164-491A-BEE4-ED98CB9882F3Q38300717-FE195198-3C2A-49BE-BECF-9FAC2F065693Q38300844-C56084E8-4B8E-4BB2-87A2-9FBA2025B63AQ38364827-3679890F-6B3A-424D-8E14-7B05FB3718BEQ40196235-71AB3269-0898-4F5E-817F-00640BF2329BQ45855863-3EAFE3AE-2A4C-48F1-B1E7-AA9306C8442AQ50479884-9E17F4FE-8E1B-4C9B-89D8-D65ABE947080
P2860
RNA splicing manipulation: strategies to modify gene expression for a variety of therapeutic outcomes.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
RNA splicing manipulation: str ...... riety of therapeutic outcomes.
@ast
RNA splicing manipulation: str ...... riety of therapeutic outcomes.
@en
type
label
RNA splicing manipulation: str ...... riety of therapeutic outcomes.
@ast
RNA splicing manipulation: str ...... riety of therapeutic outcomes.
@en
prefLabel
RNA splicing manipulation: str ...... riety of therapeutic outcomes.
@ast
RNA splicing manipulation: str ...... riety of therapeutic outcomes.
@en
P1433
P1476
RNA splicing manipulation: str ...... ariety of therapeutic outcomes
@en
P2093
Steve D Wilton
P304
P356
10.2174/156652305774329249
P407
P50
P577
2005-10-01T00:00:00Z